SACHS BIOCAPITAL USA FORUMUSANew York Academy of Sciencesst21 March 2018

For Pharma - Biotech Partnering & Investment Opportunities

“What Smart Biotechs are Doing to De�ne Value Payers will Pay for" by Roger Longman, CEO, Real Endpoints08:30

Latest Trends in DealMaking PanelCo-Chaired by:Beth Jacobs, Managing Partner, Excellentia Global PartnersGinger Johnson, CEO, De�ned Health, a Cello Health businessPanelists:Monika Vnuk, Executive Director, Business Development, P�zer, Inc.Sarah Solomon, Partner, Goodwin Procter LLPStuart Barich, Managing Director, Raymond James Financial, Inc.

08:55

“O�-The-Shelf CAR-Ts: How to Overcome CAR T Immunotherapy Limitations” by André Choulika, Chairman and CEO, Cellectis09:40

Co�ee Break10:00

Registration & Co�ee07:30

Welcome Speech by Beth Jacobs, Managing Partner, Excellentia Global Partners08:20

Future of IO: Technologies & Market Opportunities PanelCo-Chaired by:Maury Raycroft, Senior Biotech Analyst, Je�eries, LLCPaul Rennert, President & CSO, Aleta BiotherapeuticsPanelists:Adrian Woolfson, CMO, Nouscom AGKaren LaRochelle, CBO, PsiOxus Therapeutics Ltd.Niels Emmerich, Head, Search & Evaluation Oncology, AbbVie, Inc. Peter Hoang, President & CEO, TapImmune, Inc.

10:15

Advances in Cell & Gene Therapies PanelChaired by:Briana Warschun, Associate Healthcare Analyst, Edison GroupPanelists:Luc St-Onge, Head of Business Development & Licensing, apceth Biopharma GmbHSam Alworth, Chief Executive O�cer, AcuraStem, Inc.

11:00

Renewed Approaches for Neuroscience PanelChaired by:Sumant Kulkarni, Managing Director, Research, Biotechnology, Canaccord Genuity, Inc.Panelists:Bruce Leuchter, Managing Director, PJT PartnersEugene Williams, Executive Chairman, ProMIS™ Neurosciences, Inc.Gerald Commissiong, President & CEO, Amarantus BioScience Holdings, Inc.Jim DeMesa, CEO, Emerald Health Pharmaceuticals, Inc. Laszlo Kiss, Global Neuroscience Lead, ES&I, P�zer, Inc.Lynn Durham, CEO, Stalicla SA

11:45

Networking Lunch12:30

AZTherapies, Inc.11:00

Stalicla SA11:20

Cue Biopharma, Inc. [Canceled]11:40

Biosceptre International Limited12:00

Cantex Pharmaceuticals, Inc.12:10

VLP Therapeutics [Canceled]12:20

Wi-Fi info:

�

PR Track AModerated by John Nolan

WBB Asset Management, LLC

nyasguestnyasguest7WTC

��

::

Emerald Health Pharmaceuticals, Inc.

MaxCyte, Inc. [Canceled]

TapImmune, Inc. [NASDAQ: TPIV]

Hemispherx Biopharma, Inc. - [NYSEAMERICAN: HEB]

apceth Biopharma GmbH

Nouscom AG

Elto Pharma (an Amarantus company)[OTCMKTS: AMBS]

Innovus Pharmaceuticals, Inc. [OTCMKTS: INNV]

LB Pharmaceuticals, Inc.

NEMUS Bioscience, Inc. [OTCMKTS: NMUS]

Tilray

AcuraStem, Inc.

Co�ee Break

14:40

15:00

15:20

15:40

16:00

Rising Stars Session moderated by Fiona Mack, Director External Innovation, Roche Innovation Centre17:20 1. Advanced Proteome Therapeutics

2. ImmunoBiochem Corporation 3. Manhattan BioSolutions4. Mediphage Bioceuticals, Inc.

5. Sevengenes, Inc.

Networking Reception17:50

End of the BCUSA Forum18:50

Networking Lunch12:30

“Clinical Development Strategies and Programs” - Medical Cannabis PanelChaired by:Michael Farley, Director, Valor Management S.A.Panelists:Brian Murphy, Chief Executive O�cer & Chief Marketing O�cer, NEMUS Bioscience, Inc.Robert Brooke, Chief Executive O�cer, Vitality Biopharma, Inc.Woody Pastorius, Chief Operating O�cer, Tilray

13:30

16:20

Investor Roundtable - Virtual SessionCo-Chaired by:Bibhash Mukhopadhyay, Principal, NEAKuldeep Neote, Senior Director, New Ventures/Scout, Johnson & Johnson Innovation Center-BostonPanelists:Christine Brennan, Partner, MRL Ventures FundDennis Purcell, Founder and Senior Advisor, Aisling Capital, LLCJoep Muijrers, Portfolio Manager and Partner, LSPPeter Kash, Co-Founder and Vice-Chairman, TargImmune Therapeutics AG Vincent Miles, Partner, Abingworth LLP

16:35

14:20

14:40

15:00

15:20

15:40

16:00

14:20

Supported by:

PR Track B Moderated by Robert Wotczak, Wotczak Group PR Track C Moderated by Gregg Jackson, Gershon MedTech

Vitality Biopharma, Inc. [OTCMKTS: VBIO]14:00 ProMIS™ Neurosciences, Inc. [TSX:PMN] [OTCQB:ARFXF]14:00